Erasca, Inc.
NASDAQ:ERASBiotechnology
-$0.02 today
- Market cap
- $4.83B
- Beta
- 0.73
- P/E (TTM)
- -15.3
- EPS (TTM)
- -$0.91
Volume 8.94M
Average 6.79M
ERAS Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Erasca, Inc.NASDAQ: ERAS
Net Income · Q3 FY2026 · quarter ended Sep 2026
Net income grows, but more slowly than its trailing trend
Q3 FY2026 net income of $51.33M (cash outflow) rose 67.7% year over year, behind the +141.2% change in trailing-twelve-month net income. Sequentially, it rose 16.5% from the prior quarter. Over 3 fiscal years it compounded at -20.0% a year.
Context
- Net income grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 5 analysts of -$266.69M (+114.1%) for the fiscal year ending Dec 2026, a step up from the -23.0% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- -$51.33M+16.5% QoQ
- Last fiscal yearDec 2025
- -$124.55M-23.0% YoY
- LTMSep 2026
- -$307.94M+141.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +67.7% | +35.3% | -32.4 pp |
| 1 year | -23.0% | +114.1% | +137.1 pp |
| 3-year CAGR | -20.0% | +23.0% | +43.0 pp |
| 5-year CAGR | -3.0% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (124.55M) USD
- Year-over-year change
- +23.0%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (124.55M) | +23.0% |
| FY2024 | 2024-12-31 | (161.65M) | -29.3% |
| FY2023 | 2023-12-31 | (125.04M) | +48.5% |
| FY2022 | 2022-12-31 | (242.81M) | -97.8% |
| FY2021 | 2021-12-31 | (122.76M) | — |
Net Income vs competitors
How ERAS compares with its peers on the latest reported figures
- ERAS's LTM Sep 2026 net income of $307.94M is the 2nd largest of the 9 companies compared; the peer median is $169.6M.
- Its year-over-year change of +141.2% is the 2nd highest of 9, against a peer median of +46.1%.
- Over three fiscal years its annual growth of -20.0% compares with a peer median of +26.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.77B | +117.8% | +65.7% | — | |
| LTM Sep 2026 | $307.94M | +141.2% | -20.0% | — | |
| LTM Mar 2026 | $294.57M | +62.0% | +27.1% | 411.2% | |
| LTM Sep 2026 | $208M | +106.9% | -2.1% | — | |
| LTM Mar 2026 | $193.96M | +30.3% | +41.6% | 391.2% | |
| LTM Mar 2026 | $145.24M | +14.0% | +65.2% | — | |
| LTM Mar 2026 | $140.06M | -54.4% | +24.7% | 62.2% | |
| LTM Mar 2026 | $135.21M | +1.8% | +13.3% | — | |
| LTM Jun 2026 | $112.24M | +155.3% | +25.2% | 66.1% | |
| Peer median (excluding ERAS) | $169.6M | +46.1% | +26.1% | 228.6% | |
Competitors are the stored peer set for ERAS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (122.76M) | (242.81M) | (125.04M) | (161.65M) | (124.55M) |
| Depreciation & Amortization | 829K | 2.64M | 3.73M | 3.81M | 3.11M |
| Deferred Income Tax | (1.51M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 8.33M | 20.11M | 26.23M | 26.97M | 24.9M |
| Change in Working Capital | 7.71M | 15.79M | 813K | 1.74M | (3.33M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 1.34M | 676K | (886K) | (1.53M) | 513K |
| Other Working Capital | 6.36M | 15.11M | 1.7M | 3.27M | (3.84M) |
| Other Non-Cash Items | 27.81M | 101.01M | (6.95M) | 19.72M | 4.41M |
| Operating Cash Flow | (79.6M) | (103.26M) | (101.22M) | (109.42M) | (95.46M) |
| Capital Expenditures | (18.89M) | (16.55M) | (1.78M) | (22.56M) | (128K) |
| Acquisitions (Net) | 7.68M | 4M | 0 | 0 | 0 |
| Purchases of Investments | (105.82M) | (134.33M) | (314.39M) | (403.38M) | (150.97M) |
| Sales of Investments | 60.11M | 79.8M | 244.95M | 269.33M | 261.03M |
| Other Investing Activities | (7.68M) | (4M) | (20M) | (22.5M) | (9.5M) |
| Investing Cash Flow | (64.59M) | (71.08M) | (91.22M) | (156.62M) | 100.43M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 317M | 95.25M | 1.3M | 239.06M | 1.1M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.01M | 2.82M | 0 | 1.64M | 0 |
| Financing Cash Flow | 439.4M | 98.08M | 1.3M | 240.7M | 1.1M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 295.21M | (76.27M) | (191.14M) | (25.34M) | 6.07M |
| Free Cash Flow | (98.49M) | (119.82M) | (102.99M) | (131.98M) | (95.58M) |
Erasca, Inc.
NASDAQ:ERAS
Intrinsic Alpha fair value
Locked
Current Price
$13.76
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.